What You Should Know:
– NVIDIA announced collaborations with key players like IQVIA, Illumina, Mayo Clinic, and Arc Institute to accelerate drug discovery, enhance genomic research, and pioneer advanced healthcare services using agentic and generative AI.
– These strategic partnerships and technologies mark a significant step forward in the application of AI in healthcare.
AI is Transforming Healthcare
The convergence of AI, accelerated computing, and biological data is rapidly turning healthcare into a major technology industry. NVIDIA’s latest technologies are empowering healthcare leaders to develop innovative solutions that will advance human health.
Key Partnerships and Initiatives
- IQVIA: Leveraging NVIDIA AI Foundry services to build custom foundation models on its vast dataset and develop agentic AI solutions to speed research and clinical development.
- Illumina: Collaborating with NVIDIA to unlock the next generation of genomics for drug discovery and human health, making genomic analysis more accessible to researchers and life sciences companies.
- Mayo Clinic: Partnering with NVIDIA to accelerate the development of next-generation pathology foundation models using NVIDIA DGX™ Blackwell systems and MONAI, paving the way for AI applications in drug discovery, personalized diagnostics, and treatments.
- Arc Institute: Working with NVIDIA to develop and share powerful AI models and tools for biomedical discovery, scaling the potential of foundation models for biology and advancing applications in drug discovery, synthetic biology, and disease research.
“AI offers an exceptional opportunity to advance healthcare and life sciences with tools that help providers detect diseases earlier and discover new treatments faster,” said Kimberly Powell, vice president of healthcare at NVIDIA. “The combination of NVIDIA’s AI and accelerated computing capabilities with the expertise of industry leaders is poised to usher in a new era of medical and biological innovation and improve patient outcomes worldwide.“
